Nanotechnology Environmental Health and Safety
Risks, Regulation and Management
- 1st Edition - April 1, 2000
- Authors: Matthew Hull, Diana Bowman
- Editors: Matthew Hull, Diana Bowman
- Language: English
- Hardback ISBN:9 7 8 - 0 - 8 1 5 5 - 1 5 8 6 - 9
- eBook ISBN:9 7 8 - 0 - 8 1 5 5 - 1 9 8 2 - 9
This book tackles the debate over nanotechnology's environmental health and safety (EHS) by thoroughly explaining EHS issues, financial implications, foreseeable risks (i.e. ex… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteThis book tackles the debate over nanotechnology's environmental health and safety (EHS) by thoroughly explaining EHS issues, financial implications, foreseeable risks (i.e. exposure, dose, hazards of nanomaterials), and the implications of occupational hygiene precautions and consumer protections.
Real-world case studies are included, e.g. the discussion of a leading chemical company's unusual pairing with the USA's largest environmental NGO, and an innovative program designed for small- to mid-sized businesses, which became a model approach for proactive nanotechnology EHS risk management.
- Considers the potential of nanotechnology from multiple perspectives (NGO, insurance industry, small business, etc)
- Provides guidance and advice for appropriate, proactive risk management strategies
- Reviews toxicological studies and industrial initiatives, documented with actual case studies
- Of significant interest to CEOs/CTOs of technology companies (SMEs), Health and Safety officers of technology companies (SMEs), Government officials (HSE), Toxicology experts, and venture capitalists
Middle and upper management in current nanotech companies. Environmental, health and safety directors and personnel. Nanotechnology start-up ventures, especially in the nanomaterials sector. This book is of significant interest to CEOs/CTOs of technology companies (SMEs), Health and Safety officers of technology companies (SMEs), Government officials (HSE), Toxicology experts, and venture capitalists.
SECTION 1: Risks: What are Some of the Risks?
1. Toxicological studies with nanoscale materials2. Are we willing to heed the lessons of the past? Nanomaterials and Australia's asbestos legacy
SECTION 2: Regulation: How are they Currently Regulated?
3. Global perspectives on the oversight of nanotechnologies4. A nanotechnology legal framework
SECTION 3: Management: What is Being Done to Manage them?
5. Nanotechnology risk management: An insurance industry perspective6. Industry-led initiative for occupational health and safety7. Nanotechnology risk management and small business: A case study on the nanosafe framework8. A case study of a nanoscale-research facility safety through design and operation
- No. of pages: 352
- Language: English
- Edition: 1
- Published: April 1, 2000
- Imprint: William Andrew
- Hardback ISBN: 9780815515869
- eBook ISBN: 9780815519829
MH
Matthew Hull
DB
Diana Bowman
MH
Matthew Hull
DB